Coagulation pathways and diabetic retinopathy: Abnormal modulation in a selected group of insulin dependent diabetic patients

British Journal of Ophthalmology

Volumn 84, Issue 6, 2000, Pages 591-595

  Giusti, Cristiano ^a   Schiaffini, Riccardo ^b   Brufani, Claudia ^b   Pantaleo, Antonio ^b   Vingolo, Enzo Maria ^a   Gargiulo, Patrizia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Institute of Internal Medicine II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCOAGULABILITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FACTOR VII; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0034039421     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.6.591     Document Type: Article

References (49)

1. Moss SE, Klein R, Klein BEK. The 14-year incidence of vision loss in a diabetic population. Ophthalmology 1998;105:998-1003.
2. Klein R, Klein BEK, Moss SE. Retinopathy in young-onset diabetic patients. Diabet Care 1985;8:311-5.
3. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864-71.
4. 1c) to the risk of development and progression of retinopathy in the diabetes control and complication trial. Diabetes 1995;44:968-83.
5. Klein R, Klein BEK, Moss SE, et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989;149:2427-32.
6. Klein R, Klein BEK, Moss SE, et al. The relationship of hyperglycemia to long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
7. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
8. Rand LI, Krolewski AS, Aiello LM, et al. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433-8.
9. Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995;44:796-801.
10. Dornan TL, Ting A, McPherson CK. Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes 1982;31:226-31.
11. Baker RS, Rand LI, Krolewski AS, et al. Influence of HLA-DR phenotype and myopia on the risk of nonproliferative and proliferative diabetic retinopathy. Am J Ophthalmol 1986;102:693-700.
12. Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 1983;118: 228-38.
13. Moss SE, Klein R, Klein BEK. Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology 1994;101:77-83.
14. Giusti C, Pannarale L, Pazzaglia S, et al. Incidence of diabetic retinopathy in myopic eye. (ARVO abstract) Invest Ophthalmol Vis Sci 1996;37(4 suppl):S958.
15. Klein R. Barriers to prevention of vision loss caused by diabetic retinopathy. Arch Ophthalmol 1997;115:1073-5.
16. Baker RS, Watkins NL, Wilson MR, et al. Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic. Ophthalmology 1998;105:1373-9.
17. The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647-61.
18. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874-86.
19. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997;46:1829-39.
20. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus: call for data. Diabetes 1991;40:653-9.
21. Laurenti O, Vingolo EM, Desideri GB, et al. Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage. Exp Clin Endocrinol Diabetes 1997;105:40-2.
22. Letizia C, Iannaccone A, Cerci S, et al. Circulating endothelin-1 in non-insulin-dependent diabetic patients with retinopathy. Horm Metab Res 1997;29:247-51.
23. Walmsley D, Hampton KK, Grant PF. Contrasting fibrinolytic responses in type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes. Diabetic Med 1991;8: 954-9.
24. Pandolfi M, Almer LO, Holmberg L. Increased von Willebrand-antihaemophilic factor A in diabetic retinopathy. Acta Ophthalmol Scand 1974;52:823-8.
25. Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses: mediator and mechanism. J Clin Invest 1989;84:1373-8.
26. Fuller JH, Keen H, Jarret RJ. Haemostatic variables associated with diabetes and its complications. BMJ 1979;2:964-6.
27. Garcia Frade LJ, De la Calle H, Torado MC, et al. Hypofibrinolysis associated with vasculopathy in non-insulin-dependent diabetes mellitus. Thromb Res 1990;59:51-9.
28. Mansfield MW, Grant PJ. Fibrinolysis and diabetic retinopathy in NIDDM. Diabetes Care 1995;18:1577-81.
29. Haefliger IO, Meyer P, Flammer J, et al. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol 1994;39:123-32.
30. Kohner EM, Patel V, Rassman SMB. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995;44:603-7.
31. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia 1993;36:1119-25.
32. Colmann RW, Hirsh J, Marder VJ, et al. Retinal microangiopathy, hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott, 1987.
33. Matsuda T, Morishita E, Jokaij H, et al. Mechanism on disorders of coagulation and fibrinolysis in diabetes. Diabetes 1996;45(3 suppl):S109-10.
34. National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
35. Mogensen CE, Schmitz O. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin N Am 1988;72:1465.
36. Diabetic Retinopathy Study Research Group. Report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-26.
37. Boyer C, Wolf M, Rotschild C, et al. An enzyme immunoassay (ELISA) for the quantification for human factor VII. Thromb Haemost 1986;56:250-5.
38. Poggio M. Specific assays of haemostasis proteins: factor VII. Ric Clin Lab 1990;20(2):139-41.
39. Tietel JM, Bauer KA, Lau HK, et al. Studies on the prothrombin activation pathway utilising radioimmunoassay for the F2/F1+2 fragment and thrombin-antithrombin complex. Blood 1992;59:1086-97.
40. Ceriello A, Giacomello R, Colatutto A, et al. Increased prothrombin fragment 1+2 in type 1 diabetic patients. Haemostasis 1992;22:50-1.
41. Iwashima Y, Sato T, Watanabe K, et al. Elevation of plasma thrombomodulin level in diabetic patients with early nephropathy. Diabetes 1990;39:983-8.
42. Ford I, Singh TP, Kitchen S, et al. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications. Diabetic Med 1991;8:322-9.
43. Ceriello A, Giugliano D, Quatraro A, et al. Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988;31:889-91.
44. Kario K, Sakara T, Matsuo T, et al. Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet 1993;342:1552 (letter).
45. Gruden G, Cavallo-Perin P, Bazzan M, et al. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994;43:426-9.
46. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insight gained from studies using markers of haemostatic system activation. Blood 1987;70:343-50.
47. Miller GJ, Wilkes HC, Meade TW, et al. Haemostatic changes that constitute the hypercoagulable state. Lancet 1991;338:1079 (letter).
48. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348-52.
49. Vingolo EM, De Mattia G, Giusti C, et al. Treatment of nonproliferative diabetic retinopathy with defibrotide in noninsulin-dependent diabetes mellitus: a pilot study. Acta Ophthalmol Scand 1999;77:315-20.